Allison, A. C.1999. Squalene and squalane emulsions as adjuvants. Methods19:87–93.
2.
Asa, P. B., Y. Cao, and R. F. Garry. 2000. Antibodies to squalene in gulf war syndrome. Exp. Mol. Pathol.68:55–64.
3.
Asnis, D. S., P. P. Saltzman, and A. Melchert. 1993. Shark oil pneumonia. An overlooked entity. Chest103:976–977.
4.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2001. Ingredient Use Data. Unpublished data submitted by CTFA.2
5.
Dennis, K. J., and T. Shibamoto. 1989. Production of malonaldehyde from squalene, a major skin surface lipid, during UV-irradiation. Photochem. Photobiol.49:711–716.
6.
Desai, K. N., H. Wei, and C. A. Lamartiniere. 1996. The preventive and therapeutic potential of the squalene-containing compound, Roidex, on tumor promotion and regression. Cancer Lett.10:93–96.
7.
Doran, T. I., R. Baff, P. Jacobs, and E. Pacia. 1991. Characterization of human sebaceous cells in vitro. J. Invest. Dermatol.96:341–348.
8.
Elder, R. L., ed. 1982. Final report on the safety assessment of Squalene and Squalane. J. Am. Coll. Toxicol.1:37–56.
9.
Fan, S. R., C. C. Ho, F. L. F. Yeoh, C. J. Lin, and T. C. Lee. 1996. Squalene inhibits sodium arsenite-induced sister chromatid exchanges and micronuclei in Chinese hamster ovary-K1 cells. Mutat. Res.368:165–169.
10.
Food and Drug Administration.2001. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
11.
Gylling, H., and T. A. Miettinen. 1994. Postabsorptive metabolism of dietary squalene. Atherosclerosis106:169–178.
12.
Holms, B. C., W. W. Xu, L. Jacobsson, A. Larsson, H. Luthman, and J. C. Lorentzen. 2001. Rats made congenic for Oia3 on chromosome 10 become susceptible to squalene-induced arthritis. Human Mol. Genet.10:565–572.
13.
Kamimura, H., K. Fuchigami, H. Nioue, and R. Komada. 1991. Studies on distribution and excretion of squalane in dogs administered after 2 weeks. Fukuoka Acta Med.82:300–304.
14.
Kamimura, H., N. Koga, K. Oguri, and H. Yoshimura. 1989. Studies on distribution, excretion and subacute toxicity of squalane in dogs. Fukuoka Acta Med.80:269–280.
15.
Katdare, M., H. Singhal, H. Newmark, M. P. Osborne, and N. T. Telang. 1997. Prevention of mammary preneoplastic transformation by naturally-occurring tumor inhibitors. Cancer Lett.111:141–147.
16.
Kelly, G. S.1999. Squalene and its potential clinical uses. Altern. Med. Rev.4:29–36.
17.
Khono, Y., Y. Egawa, S. Itoh, S. Nagaoka, M. Takahashi, and K. Mukai. 1995. Kinetic study of quenching reaction of singlet oxygen and scavenging reaction of free radical by squalene in n-butanol. Biochim. Biophs. Acta1256:52–56.
18.
Kligman, L. H., and A. M. Kligman. 1979. The effect on rhino mouse skin of agents which influence keratinization and exfoliation. J. Invest. Dermatol.73:354–358.
19.
Leyden, J.1998. Pharmacokinetics and pharmacology of terbinafine and itra-conazole. J. Am. Acad. Dermatol.38:S42–S47.
20.
Mills, O. H., M. Porte, and A. M. Kligman. 1978. Enhancement of comedogenic substances by ultraviolet radiation. Br. J. Dermatol.98:145–150.
21.
Murakoshi, M., H. Nishino, H. Tokuda, A. Iwashima, J. Okuzumi, H. Kitano, and R. Iwasaki. 1992. Inhibition by squalene of the tumor-promoting activity of 12-O-tetradecanoylphorbol-13-acetate in mouse-skin carcinogenesis. Int. J. Cancer52:950–952.
22.
Nakagawa, M., T. Yamaguchi, H. Fukawa, J. Ogata, S. Komiyama, S. Akiyama, and M. Kuwano. 1985. Potentiation by squalene of the cytotoxicity of anti-cancer agents against cultured mammaliam cells and murine tumor. Jpn. J. Cancer Res.76:315–320.
23.
Pepe, R. C., A. A. Wenninger, and G. N. McEwen, Jr., eds. 2002. International cosmetic ingredient dictionary and handbook, 9th ed.Washington, DC: CTFA.
24.
Picardo, M., C. Zompetta, C. De Luca, A. Amantea, A. Faggioni, M. Nazzaro-Porro, and S. Passi. 1991. Squalene peroxides may contribute to ultraviolet light-induced immunological effects. Phtotdermatol. Photoimmunol. Photomed.8:105–110.
25.
Relas, H., H. Gylling, and T. A. Miettinen. 2001. Fate of intravenously administered squalene and plant sterols in human subjects. J. Lipid Res.42:988–994.
26.
Richter, E., and S. G. Schäfer. 1982. Effect of squalane on hexachlorobenzene (HCB) concentration in tissues of mice. J. Environ. Sci. HealthB 17:195–203.
27.
Saint-Leger, D., A. Bague, E. Cohen, and M. Chivot. 1986. A possible role for squalene in the pathogenesis of acne. I. In vitro study of squalene oxidation. Br. J. Dermatol.114:535–542.
28.
Stewart, M. E.1992. Sebaceous gland lipids. Semin. Dermatol.11:100–105.
29.
Storm, H. M., Y. Y. Oh, F. F. Kimler, and S. Norton. 1993. Radioprotection of mice by dietary squalene. Lipids28:555–559.
30.
Thiele, J. J., C. Schroeter, S. N. Hseih, M. Podda, and L. Packer. 2001. The antioxidant network of the stratum corneum. Curr. Prob. Dermatol.29:26–42.
31.
Tilvis, R., T. T. Kovanen, and T. A. Miettinen. 1982. Metabolism of squalene in human fat cells. J. Biol. Chem.257:10300–10305.
32.
Yoder, J. A., W. W. Stevens, and K. C. Crouch. 1999. Squalene: A naturally abundant mammalian skin secretion and long distance tick-attractant (acari: ixodidae). J. Med. Entomol.36:526–529.